Narayana Hrudayalaya Limited Share Price

Equities

NH

INE410P01011

Healthcare Facilities & Services

Market Closed - NSE India S.E. 05:13:55 14/06/2024 pm IST 5-day change 1st Jan Change
1,237 INR +0.88% Intraday chart for Narayana Hrudayalaya Limited -2.09% +2.94%
Sales 2024 50.18B 601M Sales 2025 * 57.6B 690M Capitalization 251B 3.01B
Net income 2024 7.89B 94.49M Net income 2025 * 7.9B 94.52M EV / Sales 2024 5.2 x
Net Debt 2024 * 3.63B 43.51M Net Debt 2025 * 6.54B 78.33M EV / Sales 2025 * 4.48 x
P/E ratio 2024
33 x
P/E ratio 2025 *
32.1 x
Employees 11,923
Yield 2024 *
0.15%
Yield 2025 *
0.19%
Free-Float 33.23%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.88%
1 week-2.09%
Current month+4.04%
1 month-1.19%
3 months-0.40%
6 months+3.72%
Current year+2.94%
More quotes
1 week
1 224.10
Extreme 1224.1
1 319.80
1 month
1 080.00
Extreme 1080
1 319.80
Current year
1 080.00
Extreme 1080
1 444.90
1 year
968.00
Extreme 968
1 444.90
3 years
444.20
Extreme 444.2
1 444.90
5 years
200.05
Extreme 200.05
1 444.90
10 years
182.80
Extreme 182.8
1 444.90
More quotes
Managers TitleAgeSince
Chief Executive Officer - 03/19/03
Director of Finance/CFO - 08/21/08
Chief Operating Officer - 01/01/01
Members of the board TitleAgeSince
Director/Board Member 71 16/15/16
Founder 71 19/00/19
Director/Board Member 47 08/23/08
More insiders
Date Price Change Volume
14/24/14 1,237 +0.88% 309,375
13/24/13 1,227 -1.83% 442,363
12/24/12 1,249 -0.40% 514,883
11/24/11 1,254 -3.87% 717,578
10/24/10 1,305 +3.27% 491,609

Delayed Quote NSE India S.E., June 14, 2024 at 05:13 pm IST

More quotes
Narayana Hrudayalaya Limited is an India-based healthcare service provider, operating a chain of multispecialty, tertiary, and primary healthcare facilities. The Company is primarily engaged in the business of rendering medical and healthcare services. It has a network of multispecialty and super specialty hospitals spread across multiple locations. The Company owns and operates certain hospitals. Its medical services include anesthesia, blood bank, bone marrow transplant (stem cell transplant), breast cancer, electrophysiology, emergency medicine, endocrinology, family medicine, gastrointestinal oncology, general surgery, geriatrics, gynecology - oncology, pulmonology, radiation oncology, hematology, heart transplant, hepatology liver transplantation and infectious diseases. The Company has a network of approximately 19 hospitals and three heart centers across India along with overseas presence at Cayman Islands, with over 5,860 operational beds and a capacity of over 6,160 beds.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
1,237 INR
Average target price
1,379 INR
Spread / Average Target
+11.48%
Consensus